Total Returns (Price + Dividend) 
Gujarat Kidney for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Intimation for Approval Of Quarterly Results And Other Businesses
06-Aug-2026 | Source : BSEGujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited standalone and consolidated financial results for the first quarter ending on June 30 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
23-Jul-2026 | Source : BSENewspaper publication of Notice of Postal Ballot
Announcement under Regulation 30 (LODR)-Change in Management
21-Jul-2026 | Source : BSEClarification in relation to appointment of Additional Director
Corporate Actions 
14 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.0%)
Held by 12 FIIs (4.88%)
Pragnesh Yashwantsinh Bharpoda (38.16%)
Khandelwal Finance Private Limited (1.67%)
10.64%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025
Annual Results Snapshot (Standalone) - Mar'26
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period